VANCOUVER, Dec. 8, 2016 /CNW/ - Reliq Health
Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) ("Reliq" or
the "Company"), a technology company focused on developing
innovative mobile health (mHealth) and telemedicine solutions for
Community-Based Healthcare, is pleased to announce that it has
opened an office in the UK to support Reliq's expansion into the
European market.
"We are very pleased to be opening an office in London, England in response to strong interest
from the UK market," said Dr. Lisa
Crossley, CEO of Reliq Health Technologies, Inc.
"Reliq recently launched a pilot with the NHS England at
Imperial College Hospital in London to validate the use of our remote
patient monitoring and care collaboration solution for patients
with chronic conditions. Opening an office in the UK allows
us to better support this pilot and acquire new customers in the UK
and the rest of Europe. Reliq's virtual care platform was
designed to reduce readmissions and improve health outcomes for
patients with chronic conditions like Congestive Heart Failure
(CHF), Chronic Obstructive Pulmonary Disease (COPD) and Diabetes.
Our technology allows patients to receive high quality care
from the comfort of their own homes, reducing the cost of care
delivery and increasing patient and family satisfaction."
Currently there are over 15 million people in England living with at least one long-term
health condition. In addition to the impact on people's lives,
long-term condition management accounts for half of all General
Practitioner appointments and 70% of hospital bed days in the
UK. Reliq Health's proprietary hardware and software supports
patients and their caregivers in the home, providing remote vitals
monitoring with alerts to clinicians as needed, audible reminders
to improve patient compliance with prescribed medication regimens
and lifestyle changes, tailored patient education and secure
communication with the entire care team.
Reliq's UK office is located at Impact Hub Westminster,
1st Floor New Zealand House, 80 Haymarket, London SW1Y 4TE. The entire funding for
the UK office was provided by the UK Department of International
Trade's Global Entrepreneur Programme, which supports entrepreneurs
and early stage technology businesses that wish to locate in the
UK.
ON BEHALF OF THE BOARD
"Dr. Lisa Crossley"
CEO and Director
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Cautionary Statements Regarding Forward Looking
Information
Certain statements in this press release
constitute forward-looking statements, within the meaning of
applicable securities laws. All statements that are not
historical facts, including without limitation, statements
regarding future estimates, plans, programs, forecasts,
projections, objectives, assumptions, expectations or beliefs of
future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve
known and unknown risks and uncertainties that could cause actual
and future events to differ materially from those anticipated in
such statements.
Forward-looking statements include, but are not limited to,
statements with respect to commercial operations, including
technology development, anticipated revenues, projected size of
market, and other information that is based on forecasts of future
results, estimates of amounts not yet determinable and assumptions
of management.
Reliq Health Technologies Inc. (the "Company") does not
intend, and does not assume any obligation, to update these
forward-looking statements except as required by law. These
forward-looking statements involve risks and uncertainties relating
to, among other things, technology development and marketing
activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially
from those expressed or implied by such forward-looking
statements.
SOURCE Reliq Health Technologies Inc.